COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Objectives: To compare the clinical cure rate for doxycycline and levofloxacin in treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and explore the response in relation to gender. Study Design: Quasi-experimental study. Place and Duration of Study: Department of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naveed Anjum, Muhammad Ali Yousaf, Saeed Bin Ayaz, Abdul Latif Khattak, Maria Yousaf, Muhammad Javad Yousaf
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2019
Materias:
R
Acceso en línea:https://doaj.org/article/bfe3eb5a756d4afbb22594f236a16733
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bfe3eb5a756d4afbb22594f236a16733
record_format dspace
spelling oai:doaj.org-article:bfe3eb5a756d4afbb22594f236a167332021-11-08T02:44:48ZCOMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE0030-96482411-8842https://doaj.org/article/bfe3eb5a756d4afbb22594f236a167332019-12-01T00:00:00Zhttps://www.pafmj.org/index.php/PAFMJ/article/view/3642/2463https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objectives: To compare the clinical cure rate for doxycycline and levofloxacin in treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and explore the response in relation to gender. Study Design: Quasi-experimental study. Place and Duration of Study: Department of Medicine, Pak Emirates Military Hospital Rawalpindi, from Nov 2015 to Jun 2016. Methodology: In this study, indoor patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease were enrolled through consecutive sampling and randomized into two groups through lottery method. Patients were randomly assigned to oral doxycycline 100 mg twice daily or oral levofloxacin 500 mg once daily for five days. The clinical and laboratory assessments of the patients were done on the 7th day to note response as clinical cure or clinical failure. Results: Mean age of the sample was 52 ± 5.5 years. Clinical cure was observed in 156 (84.8%) patients. Cure rate was found to be significantly higher in levofloxacin group as compared to the doxycycline group (91.3% vs. 78.3% respectively) (p=0.014). Significantly higher cure rate was observed for levofloxacin than doxycycline in males (p=0.026). No significant difference in the cure rate was noticed among the two treatment groups in females (p=0.289). Conclusion: Clinical cure rate for acute exacerbation of chronic obstructive pulmonary disease with levofloxacin was significantly higher in the sample as compared to doxycycline. The males from the sample showed similar difference in cure rate for the two drugs.Naveed AnjumMuhammad Ali YousafSaeed Bin AyazAbdul Latif KhattakMaria YousafMuhammad Javad YousafArmy Medical College Rawalpindiarticleacute exacerbationschronic obstructive pulmonary diseasedoxycyclineeffectivenessMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 69, Iss 6, Pp 1238-1242 (2019)
institution DOAJ
collection DOAJ
language EN
topic acute exacerbations
chronic obstructive pulmonary disease
doxycycline
effectiveness
Medicine
R
Medicine (General)
R5-920
spellingShingle acute exacerbations
chronic obstructive pulmonary disease
doxycycline
effectiveness
Medicine
R
Medicine (General)
R5-920
Naveed Anjum
Muhammad Ali Yousaf
Saeed Bin Ayaz
Abdul Latif Khattak
Maria Yousaf
Muhammad Javad Yousaf
COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
description Objectives: To compare the clinical cure rate for doxycycline and levofloxacin in treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and explore the response in relation to gender. Study Design: Quasi-experimental study. Place and Duration of Study: Department of Medicine, Pak Emirates Military Hospital Rawalpindi, from Nov 2015 to Jun 2016. Methodology: In this study, indoor patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease were enrolled through consecutive sampling and randomized into two groups through lottery method. Patients were randomly assigned to oral doxycycline 100 mg twice daily or oral levofloxacin 500 mg once daily for five days. The clinical and laboratory assessments of the patients were done on the 7th day to note response as clinical cure or clinical failure. Results: Mean age of the sample was 52 ± 5.5 years. Clinical cure was observed in 156 (84.8%) patients. Cure rate was found to be significantly higher in levofloxacin group as compared to the doxycycline group (91.3% vs. 78.3% respectively) (p=0.014). Significantly higher cure rate was observed for levofloxacin than doxycycline in males (p=0.026). No significant difference in the cure rate was noticed among the two treatment groups in females (p=0.289). Conclusion: Clinical cure rate for acute exacerbation of chronic obstructive pulmonary disease with levofloxacin was significantly higher in the sample as compared to doxycycline. The males from the sample showed similar difference in cure rate for the two drugs.
format article
author Naveed Anjum
Muhammad Ali Yousaf
Saeed Bin Ayaz
Abdul Latif Khattak
Maria Yousaf
Muhammad Javad Yousaf
author_facet Naveed Anjum
Muhammad Ali Yousaf
Saeed Bin Ayaz
Abdul Latif Khattak
Maria Yousaf
Muhammad Javad Yousaf
author_sort Naveed Anjum
title COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_short COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_full COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_fullStr COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_full_unstemmed COMPARISON OF CLINICAL CURE RATE FOR DOXYCYCLINE AND LEVOFLOXACIN IN TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_sort comparison of clinical cure rate for doxycycline and levofloxacin in treatment of acute exacerbation of chronic obstructive pulmonary disease
publisher Army Medical College Rawalpindi
publishDate 2019
url https://doaj.org/article/bfe3eb5a756d4afbb22594f236a16733
work_keys_str_mv AT naveedanjum comparisonofclinicalcureratefordoxycyclineandlevofloxacinintreatmentofacuteexacerbationofchronicobstructivepulmonarydisease
AT muhammadaliyousaf comparisonofclinicalcureratefordoxycyclineandlevofloxacinintreatmentofacuteexacerbationofchronicobstructivepulmonarydisease
AT saeedbinayaz comparisonofclinicalcureratefordoxycyclineandlevofloxacinintreatmentofacuteexacerbationofchronicobstructivepulmonarydisease
AT abdullatifkhattak comparisonofclinicalcureratefordoxycyclineandlevofloxacinintreatmentofacuteexacerbationofchronicobstructivepulmonarydisease
AT mariayousaf comparisonofclinicalcureratefordoxycyclineandlevofloxacinintreatmentofacuteexacerbationofchronicobstructivepulmonarydisease
AT muhammadjavadyousaf comparisonofclinicalcureratefordoxycyclineandlevofloxacinintreatmentofacuteexacerbationofchronicobstructivepulmonarydisease
_version_ 1718443035990163456